TransMedics
TMDX
85.25
-8.77
-9.33%
TransMedics
US · TMDX
#2536 by market cap
Listed 2019
85.25
-8.77
-9.33%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Oppenheimer moved from Buy to Hold on 2026-05-06.
Analyst consensus 9 analysts
Buy
Avg price target 104.75 +22.9%
Price target rangecurrent 85.25
Low70.00
Avg104.75
High120.00
Buy 78%
Hold 22%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | Barclays | -- | Buy | 120.00 |
| 2026-11-06 | CCORF | -- | Buy | 120.00 |
| 2026-11-06 | Piper Sandler | -- | Buy | 100.00 |
| 2026-11-06 | Baird | -- | Buy | 117.00 |
| 2026-11-06 | Stifel | -- | Hold | 70.00 |
| 2026-11-06 | J.P. Morgan | -- | Hold | 85.00 |
| 2026-11-03 | Piper Sandler | -- | Buy | 100.00 |
| 2026-11-02 | TD Cowen | -- | Buy | 120.00 |
| 2026-10-13 | CCORF | -- | Buy | 94.00 |
| 2026-10-06 | Barclays | -- | Buy | 120.00 |
| 2026-10-05 | Piper Sandler | -- | Buy | 100.00 |
| 2026-10-02 | TD Cowen | -- | Buy | 120.00 |
| 2026-10-02 | William Blair | -- | Buy | -- |
| 2026-09-22 | Needham | -- | Buy | 106.00 |
| 2026-09-11 | CCORF | -- | Buy | 95.00 |
| 2026-09-11 | Piper Sandler | -- | Buy | 100.00 |
| 2026-09-11 | Needham | -- | Buy | 106.00 |
| 2026-09-10 | William Blair | -- | Buy | -- |
| 2026-09-08 | TD Cowen | -- | Buy | 120.00 |
| 2026-09-02 | TD Cowen | -- | Buy | 120.00 |
| 2026-09-02 | Piper Sandler | -- | Buy | 90.00 |
| 2026-08-24 | Oppenheimer | -- | Hold | -- |
| 2026-08-12 | CCORF | -- | Buy | 95.00 |
| 2026-08-11 | CCORF | -- | Buy | 95.00 |
| 2026-08-05 | TD Cowen | -- | Buy | 120.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-06 | Oppenheimer | Buy → Hold | 175.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | After close | ±17.98% | +27.92% (beat) |
| 2026/Q2 | 2026-08-04 | After close | ±15.60% | -5.28% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±12.87% | -23.19% (beat) |
| 2025/Q4 | 2026-02-24 | After close | ±15.97% | -4.30% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±17.52% | +1.09% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±19.01% | +10.46% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±19.30% | +19.64% (beat) |
| 2024/Q4 | 2025-02-27 | After close | ±27.26% | +5.82% (in line) |
| 2024/Q3 | 2024-10-28 | After close | ±24.84% | -29.90% (beat) |
| 2024/Q1 | 2024-04-30 | After close | ±18.67% | +24.93% (beat) |
| 2023/Q4 | 2024-02-26 | After close | ±27.53% | +14.11% (in line) |
| 2023/Q3 | 2023-11-06 | After close | ±20.79% | +51.18% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
TransMedics discussion 0 comments